Hepatic metallothionein in patients with chronic hepatitis C: Relationship with severity of liver disease and response to treatment

American Journal of Gastroenterology

Volumn 98, Issue 5, 2003, Pages 1142-1149

  Carrera, Georges ^a   Paternain, Jose Luis ^b   Carrere, Nicolas ^b   Folch, Jaume ^b   Courtade Saïdi, Monique ^b   Orfila, Claudine ^b   Vinel, Jean Pierre ^b   Alric, Laurent ^b   Pipy, Bernard ^b  

^a CHU RANGUEIL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; METALLOTHIONEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL PROTECTION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER LEVEL; LIVER NECROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038746979     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(03)00107-2     Document Type: Article

References (43)

1. De Maria N, Colantoni A, Fagiuoli S, et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996;21:291-5.
2. Sumida Y, Nakashima T, Yoh T, et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 2000;33:616-22.
3. Lai MM. Hepatitis C virus proteins: Direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002;122:568-70.
4. Bureau C, Bernard J, Chaouche N, et al. Nonstuctural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 2001;25:23077-83.
5. Barbaro G, Di Lorenzo G, Asti A, et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: Ultrastructural and biochemical findings. Am J Gastroenterol 1999;94:2198-205.
6. Okuda M, Li K, Beard M, et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002;122:366-75.
7. Sato M, Bremner I. Oxygen free radicals and metallothionein. Free Radic Biol Med 1993;14:325-37.
8. Sciavolino PJ, Vicek J. Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. Cytokine 1995;7:242-50.
9. Daffada AA, Young SP. Coordinated regulation of ceruloplasmin and metallothionein mRNA by interleukin-1 and copper in HepG2 cells. FEBS Lett 1999;457:214-8.
10. Lee DK, Carrasco J, Hidalgo J, et al. Identification of a signal transducer and activator of transcription (STAT) binding site in the mouse metallothionein-I promoter involved in interleukin-6-induced gene expression. Biochem J 1999;337:59-65.
11. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 2000;59:95-104.
12. Sato M, Yamaki J, Oguro T, et al. Metallothionein synthesis induced by interferon alpha/beta in mice of various zinc status. Tohoku J Exp Med 1996;178:241-50.
13. Chubatsu LS, Meneghini R. Metallothionein protects DNA from oxidative damage. Biochem J 1993;291:193-8.
14. Sakurai A, Hara S, Okano N, et al. Regulatory role of metallothionein in NF-kappa B activation. FEBS Lett 1999;455:55-8.
15. Papouli E, Defais M, Larminat F. Overexpression of metallothionein-II sensitizes rodent cells to apoptosis induced by DNA cross-linking agent through inhibition of NF-κB activation. J Biol Chem 2002;277:4764-9.
16. Marusawa H, Hijikata M, Chiba T, et al. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappa B activation. J Virol 1999;73:4713-20.
17. Tai D, Tsai SL, Chen YM, et al. Activation of nuclear factor kappa B in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000;31:656-64.
18. Davis SR, Cousins RJ. Metallothionein expression in animals: A physiological perspective on function. J Nutr 2000;130:1085-8.
19. Nagamine T, Takagi H, Takayama H, et al. Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b. Biol Trace Elem Res 2000;75:53-63.
20. Takagi H, Nagamine T, Abe T, et al. Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. J Viral Hepatitis 2001;8:367-71.
21. Nagamine T, Takagi H, Hashimoto Y, et al. The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-alpha to hepatitis C patients. Biol Trace Elem Res 1997;58:65-76.
22. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
23. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
24. Young KK, Resnick RM, Myers TW, et al. Detection of hepatitis C virus RNA by a combined reverse transcriptasepolymerase chain reaction assay. J Clin Microbiol 1993;31:882-6.
25. Courtade M, Carrera G, Paternain JL, et al. Metallothionein expression in human lung and its varying levels after lung transplantation. Chest 1998;113:371-8.
26. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
27. Yasukawa K, Hirano T, Watanabe Y, et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J 1987;6:2939-45.
28. Fukuda R, Ishimura N, Ishihara S, et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver 1996;16:390-9.
29. Cerretti DP, Kozlosky CJ, Mosley B, et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992;256:97-100.
30. Alric L, Fort M, Izopet J, et al. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology 1997;113:1675-81.
31. Bonkovsky HL. Therapy of hepatitis C: Other options. Hepatology 1997;26:143S-51S.
32. McGuinness PH, Painter D, Davies S, et al. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000;46:260-9.
33. Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-20.
34. Molotkov A, Nishimura N, Satoh M, et al. Role of IL-6 in the induction of hepatic metallothionein in mice after partial hepatectomy. Life Sci 2000;66:963-70.
35. Loguercio C, De Girolamo V, Federico A, et al. Trace elements and chronic liver diseases. J Trace Elem Med Biol 1997;11:158-61.
36. Grüngreiff K. Zinc in liver disease. Trace Elem Exp Med 2002;15:67-78.
37. Tan Y, Sinniah R, Bay BH, et al. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours. J Pathol 1999;189:60-5.
38. Janssen A, Van Duijn W, Oostendorp-Van De Ruit M, et al. Metallothionein in human gastrointestinal cancer. J Pathol 2000;192:293-300.
39. Quaife C, Cherne R, Newcomb T, et al. Metallothionein overexpression suppresses hepatic hyperplasia induced by hepatitis B surface antigen. Tox Appl Pharmacol 1999;155:107-16.
40. Factor VM, Laskowska D, Jensen M, et al. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2000;97:2196-201.
41. Kudrin AV. Trace elements in regulation of NF-kappa B activity. J Trace Elem Med Biol 2000;14:129-42.
42. Woo ES, Lazo JS. Nucleocytoplasmic functionality of metallothionein. Cancer Res 1997;57:4236-41.
43. Yang CH, Murti A, Pfeffer SR, et al. IFN α/β promotes cell survival by activating NF-κB. Proc Natl Acad Sci USA 2000;97:13631-6.